Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

1.

Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer.

Keating NL, O'Malley A, Freedland SJ, Smith MR.

J Natl Cancer Inst. 2012 Oct 3;104(19):1518-23. No abstract available.

PMID:
23210129
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Is hormone ablation still the right choice for advanced prostate cancer?

Fitzpatrick JM.

BJU Int. 2007 Jul;100 Suppl 2:36-9. Review. No abstract available.

PMID:
17594357
[PubMed - indexed for MEDLINE]
3.

The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: an unresolved controversy.

Conteduca V, Di Lorenzo G, Tartarone A, Aieta M.

Crit Rev Oncol Hematol. 2013 Apr;86(1):42-51. doi: 10.1016/j.critrevonc.2012.09.008. Epub 2012 Oct 23. Review.

PMID:
23092636
[PubMed - indexed for MEDLINE]
4.

A review of the use of histrelin acetate in the treatment of prostate cancer.

Crawford ED.

BJU Int. 2009 Mar;103 Suppl 2:14-22. doi: 10.1111/j.1464-410X.2009.08384.x. Review. No abstract available.

PMID:
19228148
[PubMed - indexed for MEDLINE]
5.

Metabolic complications of androgen deprivation therapy for prostate cancer.

Saylor PJ, Smith MR.

J Urol. 2009 May;181(5):1998-2006; discussion 2007-8. doi: 10.1016/j.juro.2009.01.047. Epub 2009 Mar 14. Review.

PMID:
19286225
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Endocrine treatment of prostate cancer.

Tammela T.

J Steroid Biochem Mol Biol. 2004 Nov;92(4):287-95. Epub 2004 Dec 31. Review.

PMID:
15663992
[PubMed - indexed for MEDLINE]
7.

Cardiovascular risks of androgen deprivation therapy.

Ribeiro AF, Camara C, Segre CA, Srougi M, Serrano CV Jr.

Arq Bras Cardiol. 2010 Sep;95(3):412-5. Review.

PMID:
20944900
[PubMed - indexed for MEDLINE]
Free Article
8.

Intermittent androgen deprivation for locally advanced prostate cancer. Preliminary experience from an ongoing randomized controlled study of the South European urooncological group.

Calais da Silva F, Bono A, Whelan P, Brausi M, Queimadelos M, Portillo J, Kirkali Z, Robertson C.

Oncology. 2003;65 Suppl 1:24-8. Review. No abstract available.

PMID:
12949430
[PubMed - indexed for MEDLINE]
9.

Treatment-related diabetes and cardiovascular disease in prostate cancer survivors.

Smith MR.

Ann Oncol. 2008 Sep;19 Suppl 7:vii86-90. doi: 10.1093/annonc/mdn458. Review. No abstract available.

PMID:
18790986
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The role of intermittent androgen deprivation in prostate cancer.

Boccon-Gibod L, Hammerer P, Madersbacher S, Mottet N, Prayer-Galetti T, Tunn U.

BJU Int. 2007 Oct;100(4):738-43. Epub 2007 Jul 23. Review. No abstract available.

PMID:
17662079
[PubMed - indexed for MEDLINE]
11.

[Hot flushes in men after surgical or pharmacologic castration].

Aubert J, Vigouroux V, Doré B.

Prog Urol. 1995 Sep;5(4):507-9. Review. French.

PMID:
7581499
[PubMed - indexed for MEDLINE]
12.

[Bone and Men's Health. Hormonal therapy and bone loss in prostate cancer].

Izumi K, Mizokami A, Namiki M.

Clin Calcium. 2010 Feb;20(2):175-81. doi: CliCa1002175181. Review. Japanese.

PMID:
20118508
[PubMed - indexed for MEDLINE]
13.

[Clinical evaluation of hot flushes developing during endocrine therapy for prostate carcinoma].

Suzuki K, Kobayashi M, Tokue A.

Nihon Hinyokika Gakkai Zasshi. 2003 Sep;94(6):614-20. Review. Japanese.

PMID:
14531271
[PubMed - indexed for MEDLINE]
Free Article
14.

Emerging cardiometabolic complications of androgen deprivation therapy.

Choong K, Basaria S.

Aging Male. 2010 Mar;13(1):1-9. doi: 10.3109/13685530903410625. Review.

PMID:
20148744
[PubMed - indexed for MEDLINE]
15.
16.

The role of diethylstilbestrol in the treatment of prostate cancer.

Malkowicz SB.

Urology. 2001 Aug;58(2 Suppl 1):108-13. Review.

PMID:
11502463
[PubMed - indexed for MEDLINE]
17.

Prostate cancer, osteoporosis and fracture risk.

Allain TJ.

Gerontology. 2006;52(2):107-10. Review.

PMID:
16508318
[PubMed - indexed for MEDLINE]
18.

[The effective therapy of the hot flashes during hormone withdrawal treatment in patients with advanced prostatic carcinoma].

Kliesch S, Behre HM, Roth S.

Dtsch Med Wochenschr. 1997 Jul 25;122(30):940-5. Review. German. No abstract available.

PMID:
9280708
[PubMed - indexed for MEDLINE]
19.

[Androgen-deprivation therapy in prostate cancer: clinical evidence and future perspectives].

Pinto F, Calarco A, Totaro A, Sacco E, Volpe A, Racioppi M, D'Addessi A, Bassi PF.

Urologia. 2010 Apr-May;77(2):71-83. Review. Italian.

PMID:
20890863
[PubMed - indexed for MEDLINE]
20.

Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth.

Basaria S.

J Androl. 2008 Sep-Oct;29(5):534-9. doi: 10.2164/jandrol.108.005454. Epub 2008 Jun 20. Review.

PMID:
18567642
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk